Original Publication Date: 27 December, 2013
Publication / Source: CNS Oncology
Authors: Wolfgang Wick
Professor Wolfgang Wick* speaks to Tess O‘Neill, Head of Commissioning: Wolfgang Wick is the Chairman of the Department of Neuro-Oncology, Hertie Professor of Neuro-Oncology and Director at the National Tumor Center at the University of Heidelberg, Germany. He is conducting multicenter Phase III randomized trials for the Neuro-Oncology Working Group of the German Cancer Society, the European Organisation for Research and Treatment of Cancer as well as a number of multicenter trials with the pharmaceutical industry.